About Delifab
Delifab is a private limited company (BV/SRL) based in Grimbergen, founded in 2021. Its main activity is classified as "Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen". For the 2026 financial year, Delifab reported a profit of €45,643. That is less than the profit of €53,595 in 2025. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €334,748, up 3.6% on 2025. It employed an average of 3 full-time equivalents. Equity stands at €239,819, a solvency ratio of 48%. In 2022 it was €52,737. 5 annual accounts are available, covering 2022 to 2026.
- Activities
- Signals
-
ProfitableProfitable € 46K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 240KStrong equity provides a buffer against setbacks.
Low riskLow risk 48.5%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.55A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 94KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 103KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 7.9%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2026
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
335K
|
€
323K
|
€
209K
|
€
270K
|
|
|
€
103K
|
€
122K
|
€
27K
|
€
134K
|
|
|
€
46K
|
€
54K
|
€
-8K
|
€
95K
|
|
|
€
240K
|
€
194K
|
€
141K
|
€
148K
|
|
|
48.49%
|
37.76%
|
31.15%
|
36.28%
|
|
|
€
255K
|
€
320K
|
€
311K
|
€
260K
|
|
|
€
144K
|
€
269K
|
€
144K
|
€
160K
|
|
|
3
|
3
|
|
3.50
|
Publications 1
All publicationsFrequently asked questions
Answers to the most common questions about Delifab, based on official government data and the filed annual accounts.
What is the VAT number of Delifab?
The VAT number of Delifab is BE0761.863.140.
How many employees work at Delifab?
In 2026, Delifab employed 3.00 full-time equivalents (FTE).
When was Delifab established?
Delifab was founded in 21-01-2021.
What is the official address of Delifab?
The official address of Delifab is Hendrik Drapsstraat 35 Grimbergen 1853.
What is the legal form of Delifab?
The juridical form of Delifab is Private limited company (BV/SRL).
What is the annual revenue of Delifab?
The 2026 accounts of Delifab do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Delifab a reliable company?
Delifab is a registered Rechtspersoon with company number 0761.863.140 and can be verified through the official CBE database.
What is the credit limit of Delifab?
The estimated credit limit of Delifab is €116,482.
Is Delifab still active?
Delifab currently has the status "Normal situation" and is active.